在呼吸道中使用西普罗夫洛克萨 - 德克萨:一个范围审查
Cyrus W Abrahamson1, Abbey L Landini1, Jasmine Stewart2
1Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
The Laryngoscope
|June 11, 2025
概括
给呼吸道注射的西普罗素-脱萨 (CPD) 对呼吸道外科手术患者显示出潜在的益处,报告的副作用很少. 需要进一步的研究来证实其在非标签用途中的安全性和有效性.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喉喉狭窄症的手术治疗通常需要辅助医学疗法.
- 锡普罗素-脱甲 (CPD) 是一种潜在的治疗方法,但其在呼吸道中的使用尚未得到充分记录.
研究的目的:
- 进行对现有的关于在外科手术后在呼吸道中施用西普罗夫洛素-甲松 (CPD) 功效的文献进行范围审查.
- 评估目前关于CPD治疗气道狭窄的安全性和有效性的证据.
主要方法:
- 根据PRISMA的指导方针,在主要数据库 (PubMed,EMBASE,Cochrane图书馆,Scopus,Web of Science) 中进行了全面的文献搜索.
- 研究包括在内,如果它们涉及CPD在呼吸道中的管理,并提供全文数据;体外和动物研究被排除在外.
主要成果:
- 在2008年至2025年期间发表的8项研究符合纳入标准,评估了雾化CPD,内滴水或两者兼而有之.
- 涉及167名儿科和53名成年患者的研究表明,潜在的益处包括减少支气管镜检查,缩短住院时间,减少颗粒组织事件和早期脱.
- 副作用不常见,四项研究中有三项报告没有副作用;一项研究指出,儿科耳鼻喉科医生中观察到的副作用的发生率为4.5%.
结论:
- 目前关于气道应用的西普罗夫洛克萨-甲松 (CPD) 的文献是有限的.
- 现有数据表明,CPD具有低风险概况,并且在手术后的呼吸道狭窄症管理中可能有好处.
- 进一步的研究对于确定这种非标签治疗方法的最终安全性,最佳剂量和疗效至关重要.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
226
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
226
Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358
COPD: Management Using Bronchodilators and Corticosteroids
185
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
185
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
237
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
237
Inhaled Medications
239
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
239
Drugs Used in Upper Respiratory Disorders: Overview
183
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
183


